Evidence map›Paper›PMID 36440297›Full record

ArticleCureus2022

Dosimetric Study Comparing 3D Conformal Radiotherapy (3D-CRT), Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) in Hypofractionated One-Week Radiotherapy Regimen in Breast Cancer.

Aftab Ahmad, Saikat Das, Vipin Kharade, Manish Gupta, V P Pandey, Anju K V, Ilamparithi Balasubramanian, Rajesh K Pasricha

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Aftab AhmadDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Saikat DasDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Vipin KharadeDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Manish GuptaDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
V P PandeyDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Anju K VDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Ilamparithi BalasubramanianDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Rajesh K PasrichaDepartment of Radiation Oncology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
All India Institute of Medical Sciences Bhopal · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Recently, the one-week hypofractionated radiotherapy regimen (26 Gy in 5 fractions) for adjuvant breast radiotherapy has been shown to be non-inferior to other hypofractionated regimens (15-16 fractions). The aim of the present dosimetric study is to compare Intensity Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT) and 3D Conformal Radiotherapy (3D-CRT) for a one-week hypofractionated radiotherapy regimen (26 Gy in 5 fractions) for adjuvant breast radiotherapy. Methods A total of 30 patients with histologically proven invasive carcinoma of the breast after breast conservation surgery (BCS) or modified radical mastectomy (MRM) were considered for

Indexed as

breast radiotherapyfast forwardhypofractionated radiotherapyimrtvmat

Identifiers

PMID36440297
PMCPMC9691918
OpenAlexW4309884728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.